N. Basaran et al., HUMORAL AND CELLULAR IMMUNE PARAMETERS IN UNTREATED AND PHENYTOIN-TREATED OR CARBAMAZEPINE-TREATED EPILEPTIC PATIENTS, International journal of immunopharmacology, 16(12), 1994, pp. 1071-1077
The peripheral blood lymphocyte subsets, serum immunoglobulins (Ig A,
G, M), and C3 and C4 complement protein concentrations were determined
in 40 healthy subjects, 30 phenytoin-treated, 22 carbamazepine-treate
d and 38 untreated epileptic patients. The levels of B-lymphocytes, Ig
M and C3 complement proteins were found to be significantly higher in
untreated epileptics than in healthy controls (P<0.01, P<0.02 and P<0.
05, respectively). The absolute number of B-lymphocytes appeared to be
unaffected by phenytoin or carbamazepine treatment; however, IgM leve
ls were significantly lower in carbamazepine-treated patients than bot
h epileptic (P<0.01) and healthy (P<0.05) controls. Phenytoin-treated
patients had a significant reduction in the mean IgA and IgG levels co
mpared to healthy and epileptic controls (P<0.05). With both drug trea
tments, significantly lower T-suppressor lymphocyte counts and thus hi
gher T-helper to T-suppressor lymphocyte ratios were observed with res
pect to healthy and epileptic controls. Our results demonstrate that w
hile phenytoin decreases serum IgA and IgG levels, carbamazepine reduc
es IgM levels significantly, and untreated epileptics show immune prof
iles significantly different to those of healthy subjects, suggesting
that epilepsy per se may be associated with certain immune aberrations
induced by antiepileptic drugs.